According to Reuters, two leading vaccine candidates are in human clinical trials, and said another five experimental vaccines were also being developed and would begin clinical trials next year.
WHO’s Marie-Paule Kieny told reporters after a meeting in Geneva.
“Before the end of the first half of 2015 ... we could have available a few hundred thousand doses. That could be 200,000, it could be less or could be more,”
Researchers are testing two candidate vaccines from GlaxoSmithKline and NewLink Genetics.
“At least 5 vaccines are following closely and will be in the clinic in the first months of 2015,”